Prostate cancer (CaP) is the second leading cause of cancer death in American men. Chronic inflammation has been one of several factors associated with the development of CaP. Single-nucleotide polymorphisms (SNPs) in cytokine genes have been associated with increased inflammation, increased cytokine production and possibly increased CaP risk. However, the effects of cytokine SNPs on CaP susceptibility have not been consistent. Using the genomic DNA collected in a CaP case-control study (557 cases and 547 controls), we pilot tested the interactions of nine functionally characterized SNPs of three cytokine genes in CaP risk using the multivariate adaptive regression splines (MARS)-logit models. African-Americans with the IL102819TT genotype had a lower CaP risk [odds ratio (OR) 5 0.27, 95% confidence interval (CI) 5 0.07-1.01], but subjects with the genotype combination of IL1B2511CT/TT and IL102592CC had a higher CaP risk (OR 5 2.56, 95% CI 5 1.09-6.02). In Caucasians, higher CaP risk was associated with the IL1021082AG/GG genotype (OR 5 3.62, 95% CI 5 1.42-9.28), the genotype combination of IL1021082AA plus IL1B231TT/TC (OR 5 2.92, 95% CI 5 1.13-7.55) and the genotype combination of TNF2238GG plus IL102592AA (OR 5 2.14, 95% CI 5 1.05-4.38). Our results highlight the importance of cytokine SNPs and their interactions in CaP risk.
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Introduction
Prostate cancer (CaP) is the second leading cause of cancer death in American men with .27 500 deaths estimated in 2007 (1) . The incidence of CaP increases with age (1), family history and race/ethnicity (1) (2) (3) . A recent study suggests that $42% of the risk for CaP may be explained by heritable factors (4) . Several works based on epidemiological and genetic studies have proposed genes such as HPC1 (5), CAPB (6), BRCA1 and BRCA2 (7), as susceptibility genes for CaP. Chronic inflammation has been associated with increased risk in CaP (8) . The initiation, maintenance and pathology of the inflammatory response depend upon pro-and anti-inflammatory signals. Interleukin (IL) 1b, tumor necrosis factor (TNF)-a and IL10 are critical in the regulation of inflammation (9) (10) (11) (12) . Differential production of these cytokines has been associated with single-nucleotide polymorphisms (SNPs) (13) (14) (15) (16) (17) (18) (19) . IL1b is essential in promoting inflammation. Several IL1B SNPs have been associated with different types of cancer (20) (21) (22) (23) . TNF-a is a proinflammatory molecule involved in the initiation and maintaining of the inflammatory response. A G to A transition at position À308 of the TNF-A gene (TNF) has been associated with increased protein production in vitro (15, 18) in several diseases including cancer and infectious diseases (24) (25) (26) (27) . IL10 is an antiinflammatory cytokine that has been shown to inhibit vascular epithelial growth factor (14) , which may contribute to angiogenesis and survival of the tumor cells (28, 29) . Reduced levels of IL10 have been associated with the presence of the IL10À1082A/À819T/À592A haplotype on the IL10 gene promoter (13, 17) as well as with increased risk of cancer in several populations (25, 30, 31) . The objective of this study was to evaluate the associations of nine functionally characterized SNPs (IL1BÀ511C.T, IL1BÀ31T.C, IL1Bþ3954C.T, IL10À1082A.G, IL10À819C.T, IL10À592C.A, TNFÀ857C.T, TNFÀ308G.A and TNFÀ238G.A) with CaP risk.
Materials and methods

Study populations
DNA samples used for this clinic-based study were obtained from CaP cases and controls from the Departments of Urology and Internal Medicine of the Wake Forest University School of Medicine with sequential patient population as described previously (32) . We anticipated that the sample size for AfricanAmerican cases would be about 10-15%. Therefore, we oversampled AfricanAmerican controls (case:control 5 1:2 ratio) to increase statistical power. For Caucasian, we used case:control ratio of 1:1. All subjects received a description of the study and signed their informed consent according to the Medical Center's Institutional Review Board. The inclusion and exclusion criteria are described elsewhere (32) . A total of 200 African-Americans and 889 Caucasians were included in this study.
SNP determination
In this study, we evaluated the association of the following nine SNPs with CaP risk: three in the IL1B gene (IL1BÀ511C.T, IL1BÀ31T.C and IL1Bþ3954C.T), three in the IL10 gene (IL10À1082A.G, IL10À819C.T and IL10À592C.A) and three in the TNF gene (TNFÀ857C.T, TNFÀ308G.A and TNFÀ238G.A). All SNPs were determined by TaqMan genotyping assays (Applied Biosystems, Foster City, CA) using probes labeled with either FAM or VIC dyes. Briefly, 4 ng DNA was mixed with 2Â TaqMan Universal Master Mix (Applied Biosystems), water and the respective SNP mix, heated at 95°C for 10 min and subjected to 40 cycles of 15 s at 92°C and 1 min at 60°C. The polymerase chain reaction product was analyzed using a 7900 HT instrument (Applied Biosystems) for the presence of VIC or FAM fluorescent, or both, using the Sequence Detection System (Applied Biosystems) that determines the genotype. Controls of known genotype for each polymorphic locus were always run in parallel with each experiment per SNP analysis. In addition, four internal controls were included in each 96-well plate. The concordance of the genotypes for both types of controls was .98.5%.
Statistical analysis
Chi-square tests were used to compare the demographic and clinical characteristics between cases and controls. With differential distributions of casecontrol in the two racial groups, we performed all the statistical analyses stratified by race. The Hardy-Weinberg equilibrium (HWE) was examined for both Caucasians and African-American control groups by using the exact test (33) . Genotypes deviated from HWE were excluded before performing association analysis. Logistic regression models were used for testing the oneto-one association between CaP risk and each of the nine SNPs. The potential confounding/effect modifiers include age, smoking history, family history and benign prostatic hyperplasia (BPH). The smoking history was evaluated by whether the individual has ever smoked at least 100 cigarettes in lifetime. The existence of family history is determined by his first-degree relatives (father or brothers) with CaP. The crude and adjusted odds ratios (ORs) and 95% confidence interval (CI) were presented.
In order to evaluate SNP-SNP interactions, we pilot tested the multivariate adaptive regression splines (MARS)-logit models. The modes of inheritance (dominant, recessive or additive) and interaction patterns were automatically selected by MARS (Salford Systems, San Diego, CA). In this study, we Abbreviations: BPH, benign prostatic hyperplasia; CaP, prostate cancer; CI, confidence interval; HWE, Hardy-Weinberg equilibrium; IL, interleukin; MARS, multivariate adaptive regression spline; OR, odds ratio; SNP, singlenucleotide polymorphism; TNF, tumor necrosis factor.
Ó The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 573 allowed a maximum of 70 basis functions and 10-fold cross-validation for MARS model selection and tested up to three-way interactions (34) . In the MARS-logit hybrid model, MARS was applied as a variable screening tool and the selected terms with their extended terms were plugged in a logistic regression model for the second-step variable selection. The parent terms of the MARS-selected terms are their main and lower order interaction terms. The extended terms include all such terms selected from a MARS model with a lower order interaction (35) . For example, the parent terms of A Â B Â C were the main effects of A, B and C and the two-way interactions of A Â B, A Â C and B Â C. In a three-way interaction MARS model, all terms and their parent terms selected from the one-, two-and three-way MARS model were included. Then, we applied the second-step variable selection in a logistic model by using the stepwise automatic selection with P values of 5% as entry and removal criteria. The final model selection was based on the Bayesian information criterion (36) . Lower Bayesian information criterion value represents a better fit model. The best models for each of ethnic group were displayed as trees. SAS 9.1 (SAS Institute, Cary, NC) and MARS 2.0 were used for data management and analyses. All frequencies were model frequencies from complete data set used in the final MARS-logit models.
Results
The demographic and clinical characteristics of patients and controls are summarized in Table I . Except for smoking history, all other variables were significantly different between CaP patients and controls. About half of the CaP patients were in a range of 60-69 years old. Most controls (54.4%) reported a positive history of BPH, whereas most of CaP cases (56.6%) had a negative history of BPH. About 17% of controls reported having at least one first-degree relative with CaP, whereas almost 30% of the CaP cases reported positive family history.
The distribution of genotypes in our study was compared with that reported previously in African-American and Caucasians (Table II) . Our results are within the range of published studies (37) (38) (39) (40) (41) . Distributions of genotypes were different comparing that in AfricanAmericans and Caucasians. Based on this information, subsequent analyses were stratified by race.
The associations between each SNP and CaP risk with or without controlling for age, family history, smoking history and BPH are summarized in Table III . After adjusting for the demographic and clinical factors, African-American individuals with genotype IL10À819TT had a lower risk of CaP compared with those with the genotype IL10À819CC. Three SNPs (IL10À1082A.G, IL1BÀ31T.C and TNFÀ238G.A) did not follow HWE in AfricanAmericans and were not included in the final analyses. In Caucasians, a reduced risk of CaP was associated with the IL10À1082AA (OR 5 0.67, 95% CI 5 0.45-1.0), IL10À592CA (OR 5 0.7, 95% CI 5 0.52-0.93) and IL10À819CT (OR 5 0.72, 95% CI 5 0.53-0.98) genotypes after adjusting for age, family history, smoking history and BPH (Table II) . There was one SNP (TNFÀ857C.T) that did not follow HWE in Caucasians.
One main effect and one two-way gene-gene interaction were associated with the risk of CaP in African-Americans using the MARSlogit model (Figure 1 ). The association of the IL10À819TT genotype and lower CaP risk was marginally significant (OR 5 0.27, 95% CI 5 0.07-1.01, P 5 0.052). The genotype combination of IL1BÀ511CT/ TT and IL10À592CC was significantly associated with a higher risk of CaP (OR 5 2.56, 95% CI 5 1.09-6.02) after adjusting for age, family history, smoking history and BPH. As shown in Figure 2 , in Caucasians, one main and two two-way gene-gene interactions were significantly associated with CaP risk. An increased risk of CaP was associated with IL10À1082AG/GG (OR 5 3.62, 95% CI 5 1.42-9.28), the genotype combination of IL10À1082AA and IL1BÀ31TT/TC (OR 5 2.92, 95% CI 5 1.13-7.55) and the genotype combination of TNFÀ238GG and IL10À592AA (OR 5 2.14, 95% CI 5 1.05-4.38). We also analyzed haplotype frequencies and their association with CaP risk. However, none of the haplotypes was associated with CaP risk (results not shown).
Discussion
Defining the genetic effect on CaP has proven to be a complex issue despite the fact that several studies have shown that family history is a risk factor strongly associated with the disease (3). The results from twin studies suggested that, for most of the cancers, environmental factors seem to play a major role in determining the degree of risk of developing the malignancy (4). However, it has been shown that heritable factors may play a particularly important role in determining the risk of CaP (4, 42) . Several genes have been linked to CaP development (4-7); however, confirmatory results have been inconsistent may be due to poorly defined genetic differences between populations and by the effect of gene-gene or gene-environment interactions.
Chronic inflammation has been directly associated with the risk of developing CaP. By following a cohort of patients for 5 years, MacLennan et al. (8) have shown that a higher percentage of those patients initially diagnosed with the presence of chronic inflammation developed newly diagnosed prostate adenocarcinoma (20 versus 6% in those with no chronic inflammation involved). Since inflammation seems to be pivotal for the development of several malignancies including CaP (8, (43) (44) (45) (46) (47) and because no major gene has been consistently linked to CaP risk, it would be possible to think of SNPs on In this study, we evaluated the frequency of nine functionally characterized SNPs in three cytokine genes and their association with CaP. Our results show that Caucasians carrying the IL10À1082AA SNP had a reduced risk of CaP (OR 5 0.67, 95% CI 5 0.45-1.0). Similarly, Caucasian individuals carrying the genotypes IL10À592CA and IL10À819CT also had reduced risks of CaP (OR 5 0.7, 95% CI 5 0.52-0.93 and OR 5 0.72, 95% CI 5 0.53-0.98, respectively). These three SNPs are in linkage disequilibrium (17) forming an haplotype (IL10À1082A/À819T/À592A) that has been associated with reduced levels of IL10 (13, 17) and increased risk of cancer in several populations (25, 30, 31) . However, in our study this haplotype did not modify the risk of CaP. Other studies have suggested that higher levels of IL10 may be deleterious and in fact may promote the development of solid tumors. Fortis et al. (50) has shown that patients with malignant melanoma, pancreatic carcinoma and stomach cancer had increased levels of serum IL10 when compared with healthy controls opening the possibility that increased levels of IL10 in CaP patients are in fact involved in the pathogenesis of the disease. It is not clear how IL10 may play a dual role in the development of malignancy. By suppressing the Th1 response and by inhibiting phagocytic functions, IL10 may promote the tumor cells to evade the immune system and promote uncontrolled metastasis. In contrast, higher levels of IL10 have been associated with reduced angiogenesis via reduction of vascular epithelial growth factor expression (14) , controlling the progression of the tumor by limiting the access to blood supply. The reported differences on the role of IL10 in carcinogenesis may be in part due to the different origins of the tumor cells as well as the advanced stage of the disease.
The lack of consistency of single SNP analysis in CaP susceptibility may be due to the relatively minor effect that a single SNP may have in the expression or function of the gene. It is more probable that combinations of SNPs in haplotypes or SNP-SNP interactions may modify the risk of developing a malignancy. It was recently shown that when analyzed separately, single SNPs did not modify the risk of breast cancer (51); however, it was noted that the risk was greatly modified by SNP-SNP interactions. Using multivariate logistic models, these authors showed that SNPs on genes involved in different pathways interact and increase the risk of developing breast cancer. For example, genes like XPD (Lys751Gln), involved in DNA repair, were consistently associated with IL10À1082G.A increasing the risk depending on the alleles in both genes (46) . Other SNP-SNP interactions suggested the interaction of pathways like cell cycle and metabolism in the regulation of the overall breast cancer risk.
Because traditional logistic regression has limitations in testing high-order SNP-SNP interactions (52), we used the MARS-logit Cytokine gene polymorphisms and prostate cancer risk In African-Americans, the main effects of IL1BÀ511 and IL10À592 were not significantly associated with CaP risk but their interactions were. In Caucasians, the main effects of IL1BÀ31 and TNFÀ238 were not significantly associated with CaP risk but there were two-way SNP-SNP interactions in CaP risk. In general, the traditional modeling in detecting interaction follows the hierarchical rule, in which main effects and lower order interactions contained in a significant interaction must remain in the model even if they are not significant. Without this restriction, MARS can detect the SNP-SNP interactions with no or weak main effects. The mechanisms for differential SNP-CaP risk interactions between African-Americans and Caucasians remain unclear. First, it may be due to the frequency of individual SNPs in each population. A second possibility would be the presence of other factors (SNPs and transcription factors) that may be modulating the interaction of the different genetic markers in each population and then modifying the risk of CaP. In addition, the effect of the cytokine SNP interactions described here would be further modulated by environmental risk factors (inflammation, viral infections, smoking, environment exposures and others). Taken together, all these factors would, at the end, impact the definitive risk to the disease.
In summary, our results highlight the importance of studying the distribution of genetic determinants in different racial/ethnic groups to investigate their role in malignancy. The outcome of this study shows that multiple immune response pathways may interact with each other and modify the risk of CaP. More extensive work is needed to understand the effect that single SNP and SNP-SNP interactions may play in predicting the risk of CaP as well as in modifying the severity and the final outcome of the disease. Cytokine gene polymorphisms and prostate cancer risk
